ID   CD14_RAT                Reviewed;         372 AA.
AC   Q63691; Q6GT04;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 2.
DT   24-JUL-2024, entry version 156.
DE   RecName: Full=Monocyte differentiation antigen CD14;
DE   AltName: Full=Myeloid cell-specific leucine-rich glycoprotein;
DE   AltName: CD_antigen=CD14;
DE   Flags: Precursor;
GN   Name=Cd14;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND INDUCTION BY BACTERIAL
RP   LIPOPOLYSACCHARIDE.
RC   TISSUE=Spleen;
RX   PubMed=8598386; DOI=10.1016/0165-5728(95)00143-3;
RA   Galea E., Reis D.J., Fox E.S., Xu H., Feinstein D.L.;
RT   "CD14 mediate endotoxin induction of nitric oxide synthase in cultured
RT   brain glial cells.";
RL   J. Neuroimmunol. 64:19-28(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9201265; DOI=10.1002/jlb.61.6.736;
RA   Takai N., Kataoka M., Higuchi Y., Matsuura K., Yamamoto S.;
RT   "Primary structure of rat CD14 and characteristics of rat CD14, cytokine,
RT   and NO synthase mRNA expression in mononuclear phagocyte system cells in
RT   response to LPS.";
RL   J. Leukoc. Biol. 61:736-744(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=9784508; DOI=10.1128/iai.66.11.5089-5098.1998;
RA   Liu S., Khemlani L.S., Shapiro R.A., Johnson M.L., Liu K., Geller D.A.,
RA   Watkins S.C., Goyert S.M., Billiar T.R.;
RT   "Expression of CD14 by hepatocytes: upregulation by cytokines during
RT   endotoxemia.";
RL   Infect. Immun. 66:5089-5098(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Coreceptor for bacterial lipopolysaccharide. In concert with
CC       LBP, binds to monomeric lipopolysaccharide and delivers it to the
CC       LY96/TLR4 complex, thereby mediating the innate immune response to
CC       bacterial lipopolysaccharide (LPS). Acts via MyD88, TIRAP and TRAF6,
CC       leading to NF-kappa-B activation, cytokine secretion and the
CC       inflammatory response. Acts as a coreceptor for TLR2:TLR6 heterodimer
CC       in response to diacylated lipopeptides and for TLR2:TLR1 heterodimer in
CC       response to triacylated lipopeptides, these clusters trigger signaling
CC       from the cell surface and subsequently are targeted to the Golgi in a
CC       lipid-raft dependent pathway. Binds electronegative LDL (LDL(-)) and
CC       mediates the cytokine release induced by LDL(-) (By similarity).
CC       {ECO:0000250|UniProtKB:P08571, ECO:0000250|UniProtKB:P10810}.
CC   -!- SUBUNIT: Belongs to the lipopolysaccharide (LPS) receptor, a multi-
CC       protein complex containing at least CD14, LY96 and TLR4. Interacts with
CC       LPS-bound LPB. Interacts with LPAR1. Interacts with the TLR2:TLR6 or
CC       TLR2:TLR1 heterodimers; upon interaction with ligands such as
CC       diacylated lipopeptides and triacylated lipopeptides, respectively.
CC       Interacts with MYO18A. Interacts with FSTL1.
CC       {ECO:0000250|UniProtKB:P08571, ECO:0000250|UniProtKB:P10810}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P08571};
CC       Lipid-anchor, GPI-anchor {ECO:0000250|UniProtKB:P08571}. Secreted
CC       {ECO:0000250|UniProtKB:P08571}. Membrane raft
CC       {ECO:0000250|UniProtKB:P08571}. Golgi apparatus
CC       {ECO:0000250|UniProtKB:P08571}. Note=Soluble, secreted forms seem to
CC       exist. They may arise by cleavage of the GPI anchor.
CC       {ECO:0000250|UniProtKB:P08571}.
CC   -!- TISSUE SPECIFICITY: Detected in macrophages and peripheral blood
CC       monocytes. {ECO:0000269|PubMed:8598386}.
CC   -!- INDUCTION: Up-regulated in Kuppfer cells exposed to bacterial
CC       lipopolysaccharide (LPS). {ECO:0000269|PubMed:8598386}.
CC   -!- DOMAIN: The C-terminal leucine-rich repeat (LRR) region is required for
CC       responses to smooth LPS. {ECO:0000250|UniProtKB:P10810}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U51804; AAB01154.1; -; mRNA.
DR   EMBL; AF087943; AAC35371.1; -; mRNA.
DR   EMBL; BC061733; AAH61733.1; -; mRNA.
DR   RefSeq; NP_068512.1; NM_021744.1.
DR   AlphaFoldDB; Q63691; -.
DR   SMR; Q63691; -.
DR   IntAct; Q63691; 2.
DR   STRING; 10116.ENSRNOP00000023977; -.
DR   GlyCosmos; Q63691; 5 sites, No reported glycans.
DR   GlyGen; Q63691; 5 sites.
DR   PhosphoSitePlus; Q63691; -.
DR   SwissPalm; Q63691; -.
DR   PaxDb; 10116-ENSRNOP00000023977; -.
DR   Ensembl; ENSRNOT00000023977.7; ENSRNOP00000023977.3; ENSRNOG00000017819.7.
DR   Ensembl; ENSRNOT00065021846; ENSRNOP00065016924; ENSRNOG00065013294.
DR   GeneID; 60350; -.
DR   KEGG; rno:60350; -.
DR   UCSC; RGD:620588; rat.
DR   AGR; RGD:620588; -.
DR   CTD; 929; -.
DR   RGD; 620588; Cd14.
DR   eggNOG; ENOG502SNYQ; Eukaryota.
DR   GeneTree; ENSGT00390000005689; -.
DR   HOGENOM; CLU_062152_0_0_1; -.
DR   InParanoid; Q63691; -.
DR   OMA; SSSCQWP; -.
DR   OrthoDB; 5257257at2759; -.
DR   PhylomeDB; Q63691; -.
DR   TreeFam; TF338550; -.
DR   Reactome; R-RNO-140534; Caspase activation via Death Receptors in the presence of ligand.
DR   Reactome; R-RNO-166016; Toll Like Receptor 4 (TLR4) Cascade.
DR   Reactome; R-RNO-166020; Transfer of LPS from LBP carrier to CD14.
DR   Reactome; R-RNO-166166; MyD88-independent TLR4 cascade.
DR   Reactome; R-RNO-2562578; TRIF-mediated programmed cell death.
DR   Reactome; R-RNO-5686938; Regulation of TLR by endogenous ligand.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   Reactome; R-RNO-936964; Activation of IRF3, IRF7 mediated by TBK1, IKKEpsilon (IKBKE).
DR   Reactome; R-RNO-937041; IKK complex recruitment mediated by RIP1.
DR   Reactome; R-RNO-937072; TRAF6-mediated induction of TAK1 complex within TLR4 complex.
DR   Reactome; R-RNO-975163; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation.
DR   Reactome; R-RNO-9824878; Regulation of TBK1, IKKEpsilon (IKBKE)-mediated activation of IRF3, IRF7.
DR   PRO; PR:Q63691; -.
DR   Proteomes; UP000002494; Chromosome 18.
DR   Bgee; ENSRNOG00000017819; Expressed in liver and 19 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0046696; C:lipopolysaccharide receptor complex; ISS:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; ISS:UniProtKB.
DR   GO; GO:0001530; F:lipopolysaccharide binding; ISO:RGD.
DR   GO; GO:0001875; F:lipopolysaccharide immune receptor activity; ISO:RGD.
DR   GO; GO:0070891; F:lipoteichoic acid binding; ISO:RGD.
DR   GO; GO:0002752; P:cell surface pattern recognition receptor signaling pathway; ISO:RGD.
DR   GO; GO:0071726; P:cellular response to diacyl bacterial lipopeptide; ISS:UniProtKB.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0071223; P:cellular response to lipoteichoic acid; ISO:RGD.
DR   GO; GO:0071727; P:cellular response to triacyl bacterial lipopeptide; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0001819; P:positive regulation of cytokine production; IMP:RGD.
DR   GO; GO:0045807; P:positive regulation of endocytosis; ISO:RGD.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; ISO:RGD.
DR   GO; GO:0031666; P:positive regulation of lipopolysaccharide-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0034145; P:positive regulation of toll-like receptor 4 signaling pathway; ISS:UniProtKB.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISS:UniProtKB.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; ISO:RGD.
DR   GO; GO:0032729; P:positive regulation of type II interferon production; ISS:UniProtKB.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; ISO:RGD.
DR   GO; GO:0009617; P:response to bacterium; ISS:UniProtKB.
DR   GO; GO:0051602; P:response to electrical stimulus; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0032026; P:response to magnesium ion; IEP:RGD.
DR   GO; GO:0002237; P:response to molecule of bacterial origin; ISO:RGD.
DR   GO; GO:0034612; P:response to tumor necrosis factor; IMP:RGD.
DR   GO; GO:0034142; P:toll-like receptor 4 signaling pathway; ISO:RGD.
DR   Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 1.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR016337; Monocyte_diff_Ag_CD14.
DR   PANTHER; PTHR10630; MONOCYTE DIFFERENTIATION ANTIGEN CD14; 1.
DR   PANTHER; PTHR10630:SF3; MONOCYTE DIFFERENTIATION ANTIGEN CD14; 1.
DR   PIRSF; PIRSF002017; CD14; 1.
DR   PRINTS; PR00019; LEURICHRPT.
DR   SUPFAM; SSF52047; RNI-like; 1.
DR   PROSITE; PS51450; LRR; 4.
PE   2: Evidence at transcript level;
KW   Cell membrane; Disulfide bond; Glycoprotein; Golgi apparatus; GPI-anchor;
KW   Immunity; Inflammatory response; Innate immunity; Leucine-rich repeat;
KW   Lipoprotein; Membrane; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000255"
FT   CHAIN           18..342
FT                   /note="Monocyte differentiation antigen CD14"
FT                   /id="PRO_0000020891"
FT   PROPEP          343..372
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000020892"
FT   REPEAT          57..84
FT                   /note="LRR 1"
FT   REPEAT          85..120
FT                   /note="LRR 2"
FT   REPEAT          121..146
FT                   /note="LRR 3"
FT   REPEAT          147..174
FT                   /note="LRR 4"
FT   REPEAT          175..198
FT                   /note="LRR 5"
FT   REPEAT          199..226
FT                   /note="LRR 6"
FT   REPEAT          227..253
FT                   /note="LRR 7"
FT   REPEAT          254..278
FT                   /note="LRR 8"
FT   REPEAT          279..299
FT                   /note="LRR 9"
FT   REPEAT          300..321
FT                   /note="LRR 10"
FT   REPEAT          322..346
FT                   /note="LRR 11"
FT   REGION          290..372
FT                   /note="Required for response to bacterial
FT                   lipopolysaccharide (LPS)"
FT                   /evidence="ECO:0000250|UniProtKB:P10810"
FT   LIPID           342
FT                   /note="GPI-anchor amidated asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        39
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        46
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        153
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        186
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        282
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        25..38
FT                   /evidence="ECO:0000250|UniProtKB:P08571"
FT   DISULFID        36..53
FT                   /evidence="ECO:0000250|UniProtKB:P08571"
FT   DISULFID        189..219
FT                   /evidence="ECO:0000250|UniProtKB:P08571"
FT   DISULFID        243..272
FT                   /evidence="ECO:0000250|UniProtKB:P08571"
FT   CONFLICT        56
FT                   /note="Missing (in Ref. 1; AAB01154)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        220
FT                   /note="P -> S (in Ref. 1; AAB01154)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        269
FT                   /note="T -> A (in Ref. 1; AAB01154)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   372 AA;  40054 MW;  E99DD2C551DBBE69 CRC64;
     MKLMLGLLLL PLTLVHASPA TPEPCELDQD EESVRCYCNF SDPQPNWSSA FLCAGAEDVE
     FYGGGRSLEY LLKRVDTEAN LGQYTDIIRS LPLKRLTVRS ARVPTQILFG TLRVLGYSGL
     RELTLENLEV TGTALSPLLD ATGPDLNTLS LRNVSWATTD TWLAELQQWL KPGLKVLSIA
     QAHSLNFSCK QVGVFPALAT LDLSDNPELG EKGLISALCP HKFPTLQVLA LRNAGMETTS
     GVCSALAAAR VPLQALDLSH NSLRDTAGTP SCDWPSQLNS LNLSFTGLEH VPKGLPAKLS
     VLDLSYNRLD RKPRPEELPE VGSLSLTGNP FLHSESQSEA YNSGVVIATA LSPGSAGLSG
     TLALLLGHRL FV
//
